How Auerbach was paid
$3.1M in total for 2025, as reported in the Summary Compensation Table. Equity awards are valued at grant, not at what they turned out to be worth.
Named executive officers
| Executive | Salary | Bonus | Stock | Options | Incentive | Other | Total |
|---|---|---|---|---|---|---|---|
| Alan H. AuerbachPresident and Chief Executive Officer | $931,333 | — | $551,549 | $535,513 | $1,027,307 | $16,635 | $3,062,337 |
| Maximo F. NouguesChief Financial Officer | $562,961 | $130,607 | $170,848 | $165,881 | $191,069 | $19,849 | $1,241,215 |
| Jeff J. LudwigChief Commercial Officer | $264,880 | — | $132,998 | $129,131 | — | $949,159 | $1,476,167 |
| Douglas Hunt, B.Sc. (Hons)Chief Regulatory Affairs, Medical Affairs, and Pharmacovigilance Officer | $489,060 | $122,265 | $133,765 | $129,878 | $165,987 | $20,445 | $1,061,400 |
What changed and why
- $3.1MCEO total compensation decreased to $3,062,337 in fiscal 2025 from $3,969,931 in fiscal 2024.
- Stock and option awards for executives were granted based on approved aggregate values using a 30-calendar day average stock price.
- $949KJeff J. Ludwig terminated employment in May 2025, receiving severance payments and benefits totaling $949,159.
- 95%Stockholders approved executive compensation with approximately 95% support at the previous annual meeting.
About this page
Figures are automated and can be wrong; check the filing for the exact numbers. Totals follow SEC rules, which value stock and option awards at grant. Read the DEF 14A proxy statement for footnotes and the compensation committee's full reasoning.